Posttransplant sarcopenia: An underrecognized early consequence of liver transplantation

Digestive Diseases and Sciences

Volumn 58, Issue 11, 2013, Pages 3103-3111

  Dasarathy, Srinivasan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cirrhosis; Immunosuppressants; Liver transplantation; Posttransplant sarcopenia

Indexed keywords

BODY COMPOSITION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; MUSCLE MASS; PHYSICAL ACTIVITY; POSTTRANSPLANT SARCOPENIA; PRIORITY JOURNAL; REVIEW; SARCOPENIA; SKELETAL MUSCLE; TREATMENT OUTCOME;

HUMANS; LIVER TRANSPLANTATION; SARCOPENIA;

EID: 84889599814     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2791-x     Document Type: Review

References (94)

1. Aberg F, Isoniemi H, Hockerstedt K. Long-term results of liver transplantation. Scand J Surg. 2011;100:14-21.
2. Gouw AS, Haagsma EB, Manns M, Klompmaker IJ, Slooff MJ, Gerber MA. Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors. J Hepatol. 1994;20:500-507.
3. Schott R, Chaouat A, Launoy A, Pottecher T, Weitzenblum E. Improvement of pulmonary hypertension after liver transplantation. Chest. 1999;115:1748-1749.
4. Sussman AN, Boyer TD. Management of refractory ascites and hepatorenal syndrome. Curr Gastroenterol Rep. 2011;13:17-25.
5. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle. 2012;3:225-237.
6. Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis. 2012;16:95-131.
7. Merli M, Giusto M, Gentili F, et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010;30:208-214.
8. Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8:979-985.
9. Merli M, Giusto M, Giannelli V, Lucidi C, Riggio O. Nutritional Status and Liver Transplantation. J Clin Exp Hepatol. 2011;1:190-198.
10. Neff GW, Duncan CW, Schiff ER. The current economic burden of cirrhosis. Gastroenterol Hepatol (N Y). 2011;7(10):661-671.
11. Duffy JP, Kao K, Ko CY, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg. 2010;252:652-661.
12. Santos JR, Miyazaki MC, Domingos NA, Valerio NI, Silva RF, Silva RC. Patients undergoing liver transplantation: psychosocial characteristics, depressive symptoms, and quality of life. Transpl Proc. 2008;40:802-804.
13. Saab S, Wiese C, Ibrahim AB, et al. Employment and quality of life in liver transplant recipients. Liver Transpl. 2007;13:1330-1338.
14. Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol. 2006;12:3380-3385.
15. Thoresen L, Frykholm G, Lydersen S, et al. The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl). 2012;21:505-516.
16. Verhage TL, Heijdra Y, Molema J, Vercoulen J, Dekhuijzen R. Associations of muscle depletion with health status. Another gender difference in COPD? Clin Nutr. 2011;30:332-338.
17. Vetta F, Ronzoni S, Taglieri G, Bollea MR. The impact of malnutrition on the quality of life in the elderly. Clin Nutr. 1999;18:259-267.
18. Williams TJ, McKenna MJ. Exercise limitation following transplantation. Compr Physiol. 2012;2:1937-1979.
19. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl. 2009;15:1662-1670.
20. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96:2898-2903.
21. Kim TN, Park MS, Lim KI, et al. Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract. 2011;93:285-291.
22. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10(166-73):173.
23. Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209-1216.
24. Hussaini SH, Oldroyd B, Stewart SP, et al. Effects of orthotopic liver transplantation on body composition. Liver. 1998;18:173-179.
25. Keogh JB, Tsalamandris C, Sewell RB, et al. Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal study. Nutrition. 1999;15:661-664.
26. Plank LD, Metzger DJ, McCall JL, et al. Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery. Ann Surg. 2001;234:245-255.
27. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Dodd MJ, Painter PL. Objective measures of health-related quality of life over 24 months post-liver transplantation. Clin Transpl. 2005;19:1-9.
28. Krasnoff JB, Vintro AQ, Ascher NL, et al. A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transpl. 2006;6:1896-1905.
29. Merli M, Guisto M, Riggio O, Gentili F, Molinaro A, Attili A, et al. Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation. Eur E J Clin Nutr Metab. 2011;6:e142-e147.
30. de Carvalho L, Parise ER, Samuel D. Factors associated with nutritional status in liver transplant patients who survived the first year after transplantation. J Gastroenterol Hepatol. 2010;25:391-396.
31. Zaina FE, Lopes RW, Souza MR. A comparison of nutritional status in three time points of liver transplant. Transpl Proc. 2004;36:949-950.
32. Holt RI, Broide E, Buchanan CR, et al. Orthotopic liver transplantation reverses the adverse nutritional changes of end-stage liver disease in children. Am J Clin Nutr. 1997;65:534-542.
33. Wagner D, Adunka C, Kniepeiss D, et al. Serum albumin, subjective global assessment, body mass index and the bioimpedance analysis in the assessment of malnutrition in patients up to 15 years after liver transplantation. Clin Transpl. 2011;25:E396-E400.
34. Schutz T, Hudjetz H, Roske AE, et al. Weight gain in long-term survivors of kidney or liver transplantation-another paradigm of sarcopenic obesity? Nutrition. 2012;28:378-383.
35. Krasnoff JB, Mathias R, Rosenthal P, Painter PL. The comprehensive assessment of physical fitness in children following kidney and liver transplantation. Transplantation. 2006;82:211-217.
36. de Luis DA, Izaola O, Velicia MC, et al. Impact of dietary intake and nutritional status on outcomes after liver transplantation. Rev Esp Enferm Dig. 2006;98:6-13.
37. Madersbacher S, Ludvik G, Stulnig T, Grunberger T, Maier U. The impact of liver transplantation on endocrine status in men. Clin Endocrinol (Oxf). 1996;44:461-466.
38. Seehofer D, Steinmueller T, Graef KJ, et al. Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation. Ann Transpl. 2002;7:32-37.
39. Wawrzynowicz-Syczewska M, Karpinska E, Jurczyk K, Laurans L, Boron-Kaczmarska A. Risk factors and dynamics of weight gain in patients after liver transplantation. Ann Transpl. 2009;14:45-50.
40. Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int. 2005;18:461-466.
41. Toniutto P, Fabris C, Minisini R, et al. Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Transplantation. 2005;79:1338-1343.
42. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl. 2001;7:S13-S21.
43. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg. 1998;4:285-296.
44. Palmer M, Schaffner F, Thung SN. Excessive weight gain after liver transplantation. Transplantation. 1991;51:797-800.
45. Proctor DN, O'Brien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol. 1999;277:E489-E495.
46. Hussaini SH, Soo S, Stewart SP, et al. Risk factors for loss of lean body mass after liver transplantation. Appl Radiat Isot. 1998;49:663-664.
47. Langer G, Grossmann K, Fleischer S, et al. Nutritional interventions for liver-transplanted patients. Cochrane Database Syst Rev. 2012;8:CD007605.
48. Yoshida R, Yagi T, Sadamori H, et al. Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation. J Hepatobiliary Pancreat Sci. 2012;19:438-448.
49. Ebeling PR. Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab. 2009;94:1483-1490.
50. Guadalix S, Martinez-Diaz-Guerra G, Lora D, et al. Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study. Transpl Int. 2011;24:657-665.
51. Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE. Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism. Liver Transpl. 2004;10:638-647.
52. Guichelaar MM, Kendall R, Malinchoc M, Hay JE. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl. 2006;12:1390-1402.
53. Kasturi KS, Chennareddygari S, Mummadi RR. Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials. Transpl Int. 2010;23:200-207.
54. Kulak CA, Borba VZ, Kulak JJ, Shane E. Transplantation osteoporosis. Arq Bras Endocrinol Metabol. 2006;50:783-792.
55. Kulak CA, Borba VZ, Kulak J Jr, Custodio MR. Osteoporosis after transplantation. Curr Osteoporos Rep. 2012;10:48-55.
56. Maalouf NM, Sakhaee K. Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients. Curr Treat Options Gastroenterol. 2006;9:456-463.
57. Millonig G, Graziadei IW, Eichler D, et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl. 2005;11:960-966.
58. Perkins JD. Bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Liver Transpl. 2006;12:1168-1169.
59. Scolapio JS, DeArment J, Hurley DL, Romano M, Harnois D, Weigand SD. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation. JPEN J Parenter Enteral Nutr. 2003;27:427-432.
60. Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am. 2007;36:937-963.
61. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51:636-641.
62. Rantanen T, Harris T, Leveille SG, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci. 2000;55:M168-M173.
63. Dasarathy S, McCullough AJ, Muc S, et al. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol. 2011;54:915-921.
64. Garcia PS, Cabbabe A, Kambadur R, Nicholas G, Csete M. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting. Anesth Analg. 2010;111:707-709.
65. Morrison WL, Bouchier IA, Gibson JN, Rennie MJ. Skeletal muscle and whole-body protein turnover in cirrhosis. Clin Sci (Lond). 1990;78:613-619.
66. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care. 2003;6:79-85.
67. Gayan-Ramirez G, van de Casteele M, Rollier H, et al. Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. J Hepatol. 1998;29:241-249.
68. Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab. 2005;288:E493-E501.
69. Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
70. Muller MJ, Loyal S, Schwarze M, et al. Resting energy expenditure and nutritional state in patients with liver cirrhosis before and after liver transplantation. Clin Nutr. 1994;13:145-152.
71. Hasse JM, Blue LS, Liepa GU, et al. Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr. 1995;19:437-443.
72. Dickinson JM, Fry CS, Drummond MJ, et al. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. J Nutr. 2011;141:856-862.
73. Drummond MJ, Fry CS, Glynn EL, et al. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J Physiol. 2009;587:1535-1546.
74. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature. 1999;400:581-585.
75. Sakuma K, Nakao R, Aoi W, et al. Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration. Acta Neuropathol. 2005;110:269-280.
76. Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003;285:E363-E371.
77. Taylor WE, Bhasin S, Artaza J, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab. 2001;280:E221-E228.
78. Sakuma K, Yamaguchi A. The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle. J Biomed Biotechnol. 2010;2010:721219.
79. Mercier JG, Hokanson JF, Brooks GA. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med. 1995;151:1532-1536.
80. Gabe SM, Bjarnason I, Tolou-Ghamari Z, et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology. 1998;115:67-74.
81. Vary TC. IGF-I stimulates protein synthesis in skeletal muscle through multiple signaling pathways during sepsis. Am J Physiol Regul Integr Comp Physiol. 2006;290:R313-R321.
82. Tinti F, Mitterhofer AP, Muiesan P. Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors. Minerva Chir. 2012;67:1-13.
83. Miyabara EH, Conte TC, Silva MT, et al. Mammalian target of rapamycin complex 1 is involved in differentiation of regenerating myofibers in vivo. Muscle Nerve. 2010;42:778-787.
84. Painter P, Krasnoff J, Paul SM, Ascher NL. Physical activity and health-related quality of life in liver transplant recipients. Liver Transpl. 2001;7(3):213-219.
85. van den Ham EC, Kooman JP, Christiaans MH, van Hooff JP. Relation between steroid dose, body composition and physical activity in renal transplant patients. Transplantation. 2000;69:1591-1598.
86. Braith RW, Mills RM, Welsch MA, Keller JW, Pollock ML. Resistance exercise training restores bone mineral density in heart transplant recipients. J Am Coll Cardiol. 1996;28:1471-1477.
87. Braith RW, Magyari PM, Fulton MN, Aranda J, Walker T, Hill JA. Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients. J Heart Lung Transpl. 2003;22:1082-1090.
88. Drummond MJ, Dreyer HC, Fry CS, Glynn EL, Rasmussen BB. Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J Appl Physiol. 2009;106:1374-1384.
89. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation. 2000;69:1364-1369.
90. Nickkholgh A, Schneider H, Encke J, Buchler MW, Schmidt J, Schemmer P. PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantation. Trials. 2007;8:20.
91. Kyle UG, Nicod L, Raguso C, Hans D, Pichard C. Prevalence of low fat-free mass index and high and very high body fat mass index following lung transplantation. Acta Diabetol. 2003;40:S258-S260.
92. Kyle UG, Nicod L, Romand JA, Slosman DO, Spiliopoulos A, Pichard C. Four-year follow-up of body compostion in lung transplant patients. Transplantation. 2003;75:821-828.
93. Coroas AS, Oliveira JG, Sampaio S, et al. Body composition assessed by impedance changes very early with declining renal graft function. Nephron Physiol. 2006;104:115-120.
94. Harada H, Nakamura M, Hotta K, et al. Percentages of water, muscle, and bone decrease and lipid increases in early period after successful kidney transplantation: a body composition analysis. Transpl Proc. 2012;44:672-675.